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ABSTRACT
Cdc48/p97 is an evolutionary conserved ubiquitin-
dependent chaperone involved in a broad array of
cellular functions due to its ability to associate with
multiple cofactors. Aside from its role in removing
RNA polymerase II from chromatin after DNA dam-
age, little is known about how this AAA-ATPase is
involved in the transcriptional process. Here, we
show that yeast Cdc48 is recruited to chromatin
in a transcription-coupled manner and modulates
gene expression. Cdc48, together with its cofactor
Ubx3 controls monoubiquitylation of histone H2B, a
conserved modification regulating nucleosome dy-
namics and chromatin organization. Mechanistically,
Cdc48 facilitates the recruitment of Lge1, a cofac-
tor of the H2B ubiquitin ligase Bre1. The function
of Cdc48 in controlling H2B ubiquitylation appears
conserved in human cells because disease-related
mutations or chemical inhibition of p97 function af-
fected the amount of ubiquitylated H2B in muscle
cells. Together, these results suggest a prominent
role of Cdc48/p97 in the coordination of chromatin
remodeling with gene transcription to define cellular
differentiation processes.
INTRODUCTION
Genomic DNA in eukaryotic cells is arranged into nucleo-
somal repeat units to form a highly organized nucleoprotein
structure called chromatin. Each nucleosome corresponds
to 147 bp of DNA wrapped around a histone octamer core
particle that is composed of two copies of histone H2A,
H2B, H3 and H4. Different regulation pathways ensure
the correct coordination between chromatin dynamics and
DNA-associated processes, since access to DNA is required
for DNA replication, DNA repair and mRNA transcrip-
tion. In particular, post-translational modifications of hi-
stones, including ubiquitylation and de-ubiquitylation of
histone H2B, define chromatin remodeling important for
DNA replication and transcription. Besides nucleosome dy-
namics, this mark regulates trimethylation of histone H3 on
both lysine 4 by the SET1 complex and lysine 79 by the
DOT1 complex through a so-called trans-tail pathway, and
facilitates recruitment of processing and nuclear export ma-
chineries on nascent mRNA transcripts (1–7).
Ubiquitylation of histone H2B is a highly conserved
process in eukaryotes. In Saccharomyces cerevisiae, H2B
is mainly monoubiquitylated but can also be poly-
ubiquitylated on lysine 123 (K123) by the ubiquitin conju-
gation enzyme Rad6 and the ubiquitin RING ligase Bre1
(8–11). Modification of lysine 120 (K120) of human H2B
is catalyzed by hRad6 and RNF20/RNF40. Cofactors of
these enzymes have been described including Lge1 in yeast
or WAC in mammals, which support the recruitment of the
H2B E3 ligase to active transcription sites (12,13). The ubiq-
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uitin moiety on H2B can be cleaved off by two distinct deu-
biquitylation enzymes (DUBs) in yeast, Ubp10 and Ubp8,
a subunit of the SAGA (Spt-Ada-Gcn5-Acetyltransferase)
acetylation complex (14,15). Deubiquitylation of H2B fa-
cilitates the recruitment of Ctk1, a kinase that phosphory-
lates Ser-2 of the C-terminal domain of RNA polymerase
II large subunit (CTD) and the methyltransferase Set2. Cy-
cles of ubiquitylation/deubiquitylation of H2B are thus re-
quired for efficient gene expression (16).
Recent studies indicate that ubiquitylation of histone
H2B undergoes major changes during mammalian cell
differentiation. In particular, monoubiquitylation of H2B
K120 increases during differentiation of human or murine
stem cells into diverse lineages, such as osteoblasts,
adipocytes, oligodendrocytes and keratinocytes (17,18).
Such an up-regulation is required for stem cell differentia-
tion and is associated with transcriptional reprogramming.
In contrast, H2B ubiquitylation is down-regulated upon
differentiation of human myoblasts based on inefficient re-
cruitment of the E3 ligase RNF20 to chromatin in myotubes
(19).
Cdc48, also called p97 or VCP in mammals, is an evolu-
tionary conserved AAA-ATPase consisting of two adeno-
sine triphosphatase (ATPase) domains flanked by N- and
C-terminal extensions. Cdc48 primarily interacts with ubiq-
uitylated proteins and uses the energy of adenosine triphos-
phate (ATP) hydrolysis to segregate ubiquitylated sub-
strates from protein complexes, membranes or chromatin
for proteasomal degradation (20–22). Along this line, it has
been recently shown that the Rpb1 subunit of the yeast
RNA polymerase II is ubiquitylated when stalled at sites of
ultraviolet-induced DNA lesions, and extracted from chro-
matin by Cdc48-dependent segregation (23). Interestingly,
mutations in human p97 are known to cause inclusion-body
myopathy associated with Paget disease of bone and fron-
totemporal dementia (IBMPFD), however, the mechanistic
defects are still unclear (24,25).
The broad spectrum of cellular functions controlled by
Cdc48/p97 is mediated by its multiple substrate-recruiting
or substrate-processing cofactors, including E3 ligases and
DUBs (26,27). The ‘Ubiquitin Regulatory X’ (UBX) or
UBX-like containing proteins form the largest family of
Cdc48/p97 cofactors conserved from yeast to mammals.
The UBX domain interacts with the N-terminal region
of Cdc48/p97 via conserved structural features. UBX do-
main proteins display an adaptor function that recruits
Cdc48/p97 to specific substrates and cellular locations
(28,29).
Here, we identify Cdc48 and its cofactor Ubx3 as novel
regulators of H2B ubiquitylation. Cdc48 is recruited co-
transcriptionally and supports monoubiquitylation of H2B
on actively transcribed genes by controlling the recruitment
of Lge1, a cofactor of the E3 ligase Bre1 in yeast. Intrigu-
ingly, the dynamics of H2B ubiquitylation during muscle
differentiation are also affected in primary muscle cells of
IBMPFD patients. These results suggest that the involve-
ment of Cdc48 in H2B monoubiquitylation is an evolution-
arily conserved phenomenon that defines chromatin land-
scape changes important for developmental processes in-
cluding muscle differentiation.
MATERIALS AND METHODS
Yeast strains
The S. cerevisiae strains used in this study are listed in Sup-
plementary Table S1.
Preparation of yeast total extracts
Yeast cells grown in YPD or synthetic medium were col-
lected during the exponential growth phase (OD600 of 1.5
or 0.8, respectively). Total protein extracts were prepared
by the NaOH-trichloroacetic acid (TCA) lysis method (30).
Alternatively, cells were collected and resuspended in ice-
cold lysis buffer (50 mM Hepes– KOH at pH 7.4, 150 mM
NaCl, 1 mM DTT, 5% glycerol, 0.1% Triton X-100, 5 mM
N-Ethylmaleimide, protease inhibitor cocktail (Roche)) as
30 OD600 per milliliter. To analyze coimmunoprecipitation
between Ubx3-HA and Lge1-Myc, cells were lyzed in 20
mM Hepes– KOH at pH 7.5, 75 mM NaCl, 5 mM MgCl2,
10% glycerol, 0.5% Triton X-100, protease inhibitor cock-
tail (Roche). Cell suspensions were lysed at 4◦C with glass
beads in a magnalyser (Roche), and centrifuged at 13 000
rpm for 20 min at 4◦C prior to TCA precipitation and west-
ern blotting analysis.
Purification of ubiquitylated proteins
Cells transformed with a plasmid encoding 6His-ubiquitin
under the CUP1 promoter were grown on selective media
and stimulated overnight with 0.1 mM of CuSO4. A to-
tal of 100 OD600 of cells were lyzed in 6 M guanidinium–
HCl, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris–HCl pH
8.0, 0.1% Triton X-100 plus 5 mM imidazole, 10 mM
beta-mercaptoethanol, protease inhibitors, 20 mM NEM
and 100 M MG132. Purification was performed on Ni2+-
NTA-agarose beads pre-washed with lysis buffer and incu-
bated for 2 h at room temperature. The beads were washed
with 8 M urea, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris–
HCl pH 6.3, 10 mM beta-mercaptoethanol, 0.2% Triton X-
100 prior elution and western blot analysis using anti-H2B
(Active Motif) and anti-His6 antibodies (4,31).
Chromatin immunoprecipitation (ChIP) analysis
ChIPs were performed as previously described (32), with
the following modifications. Cells were crosslinked with
1.2% formaldehyde for 10 min. Sonicated extracts were cen-
trifuged for 20 min at 10 000 × g prior to overnight immuno-
precipitation, using specific antibodies coated Protein G-
Sepharose beads. After reversing crosslinking, real-time q
polymerase chain reaction (qPCR) was performed using the
SYBR Green mix (Roche) and the Light Cycler 480 system
(Roche) with gene-specific primers corresponding to 150 bp
fragments described in Supplementary Table S2. The anti-
bodies used in this ChIP assay are an anti-Cdc48 antibody
kindly provided by T. Sommer, an anti-CTD antibody that
recognizes all forms of CTD except the Ser2 phosphory-
lated form (8WG16 antibody; MMS126R, Covance), anti-
HA antibody (HA.11 antibody; MMS-101R-B, Covance),
an anti-Rpb3 antibody (W0012, Neoclone), an anti-yeast
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H2B (Active Motif; 39237) and an anti-human ubiquityl-
histone H2B that cross-reacts with the yeast protein (D11;
5546S, Cell Signaling).
Non-specific signals were systematically assessed by
analysing immunoprecipitated DNA using primers for in-
tergenic regions and used to normalize results when indi-
cated.
Chromatin double immunoprecipitation (ChDIP) analysis
ChDIPs were performed as previously described (33,34),
with the following modifications. Cells were transformed
with plasmids encoding a Flag tagged version of wt or
mutated HTB1 (pRS314-HTB1-Flag WT or pRS314-htb1-
Flag K123R). Note that 3 mg of crosslinked chromatin were
used for each overnight immunoprecipitation with 100 l of
anti Flag M2 coated-beads (Sigma-Aldrich). Immunopre-
cipitates were eluted by an overnight incubation with 100
g/ml of 3×-Flag peptide (Sigma-Aldrich) prior the second
immunoprecipitation with anti-ubiquitin antibodies (FK2
clone, Enzo Life Sciences) and Protein G-Sepharose beads.
RNA isolation and amplification
Total RNA isolation was performed by the hot acid phenol
method (Sigma Aldrich). cDNA from total RNAs were ob-
tained by retro-transcription with random oligonucleotides
(Roche) using the SuperScriptTM II reverse transcriptase
(Invitrogen). Real-time qPCR was then performed using the
SYBR Green mix (Roche) and the Light Cycler 480 system
(Roche) with gene-specific primers described in Supplemen-
tary Table S2.
Human myoblast culture and cell extracts
Human myoblasts are provided from the Muscle Tissue
Culture Collection (MTCC), which is part of the Ger-
man network on muscular dystrophies (MD-NET) and the
German network for mitochondrial disorders (mito-NET,
project D2, 01GM1113A) funded by the German Ministry
of Education and Research (BMBF, Bonn, Germany). The
MTCC is a partner of EuroBioBank (www.eurobiobank.
org) and TREAT-NMD (www.treat-nmd.eu).
Normal and IBMPFD primary human myoblasts (VCP-
Mutation R155H with age- and sex-matched controls) were
cultured in skeletal muscle cell growth medium (Provitro;
201 0602 with supplement mix 218 0602 added) at 37◦C
and 5% CO2. To induce differentiation, cells were grown
to near confluence and skeletal muscle cell growth medium
with 15% fetal calf serum was replaced by differentiation
medium (Dulbecco’s modified Eagle’s medium (DMEM)
with 2% horse serum). Myogenesis was monitored by west-
ern blot analysis of the myogenic differentiation marker
MyoD. Differentiated myotubes were separated from un-
differentiated cells with diluted trypsin. Cells were lysed for
western blotting in Laemmli sample buffer (63 mM Tris pH
6.8, 10% glycerol, 2.5% sodium dodecyl sulphate (SDS),
bromophenol blue, 5% ß-mercaptoethanol) for 4 min at
95◦C. Western blot analyses were performed using standard
procedures.
Stably transfected wild-type (wt) p97 and p97EQ U2OS
cell lines, provided by C.C. Weihl (35), were grown at 37◦C in
humidified air containing 5% CO2 in DMEM supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 1000
UI/ml penicillin, 1000 UI/ml streptomycin with the ad-
dition of selective antibiotics (100 g/ml hygromycin B
and 100 g/ml Zeocin). p97 and/or p97EQ expression
was induced with 1 g/ml tetracyline for 16 h. Next, to-
tal cell lystes were separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and subjected to western blot
analysis. C2C12 mouse myoblasts were routinely main-
tained in DMEM supplemented with 10% heat-inactivated
FBS, 1000 UI/ml penicillin, 1000 UI/ml streptomycin and
2 mM L-Glutamine at 37◦C in humidified air containing
5% CO2. C2C12 myoblasts were treated with various con-
centration of DBeQ for 2 h. Next, total cell lystes were sepa-
rated by SDS-PAGE and subjected to western blot analysis.
Western blot analyses were performed with anti-c-
Myc 1/10 000 (Sigma), anti-VCP 1/5000 (ab1433 Ab-
cam), anti-H2B 1/1000 (gift from D. Devys), anti-H2Bub
1/1000 (Medimabs), anti-MyoD1 1/1000 (Dako) and anti-
-tubulin 1/5000 (Sigma). Proteins were detected by im-
munoblotting using an ECL kit (GE Healthcare).
RESULTS
Cdc48 is recruited to actively transcribed genes
Recently, Cdc48 has been linked to chromatin-associated
degradation mainly involved in DNA damage repair path-
ways (23). To determine whether Cdc48 also regulates
transcription-associated pathways, we followed its recruit-
ment to actively transcribed genes by ChIP and qPCR
of the constitutively expressed PMA1 gene, the galactose-
inducible GAL10 gene and the heat-inducible HSP104 gene
using different primer pairs (Figure 1, Supplementary Fig-
ure S1A). Our results reveal that Cdc48 binds to the PMA1
gene with an up to 6-fold enrichment all along the gene com-
pared to the non-transcribed intergenic region (Figure 1A).
In contrast, the recruitment of the thermosensitive mutant
protein cdc48–6 was severely decreased at 30◦C, whereas
its expression level was not affected (Supplementary Fig-
ure S1B). Analysis of the inducible GAL10 gene indicated
that Cdc48 was barely detectable on this gene when cells
were grown in glucose and only associates with GAL10 dur-
ing its activation with galactose. Upon induction, Cdc48 is
recruited on GAL10 with identical kinetics to RNA poly-
merase II as analyzed using its Rpb3 subunit (Figure 1B
and C). Similarly, Cdc48 accumulated strongly on the heat-
inducible HSP104 gene upon shifting wt yeast cultures from
23◦C to 42◦C for 30 min, while this temperature stress si-
multaneously resulted in a major defect of both CTD and
Cdc48 recruitment on PMA1 (Supplementary Figure S1A).
Together these results support the idea that Cdc48 asso-
ciates with active genes in a transcription-coupled manner.
Cdc48 is known to associate with several alternative co-
factors that are involved in substrate recruitment and pro-
cessing. Among those, the Ufd1/Npl4 heterodimer is re-
quired for the role of Cdc48 in endoplasmic reticulum (ER)-
associated protein degradation and ubiquitin-dependent
extraction from chromatin (22,27). Interestingly, Cdc48 re-
cruitment was also affected in a thermosensitive mutant
lacking functional Npl4 (Supplementary Figure S1C), sug-
gesting a role for the Ufd1/Npl4 complex in this pro-
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Figure 1. Cdc48 is cotranscriptionally recruited on active genes. (A) Recruitment of Cdc48 on the PMA1 gene was analyzed by ChIP experiments per-
formed on extracts prepared from WT or cdc48–6 cells grown overnight at 30◦C using anti RNA polymerase II (CTD) or Cdc48 antibodies. Histograms
depict the mean and standard deviations of at least three independent experiments. (B) Yeast cells were induced with galactose and ChIP performed to
monitor recruitment of Rpb3 (left) or Cdc48 to the +500 position of the GAL10 ORF at the indicated timepoints. Error bars depict the mean and stan-
dard error of at least three independent experiments. (C) Yeast were grown in raffinose and transferred to media containing either galactose or glucose, as
indicated, for 60 min. ChIP was then performed with primers as indicated spanning the GAL10 locus. (D) GAL10 transcripts were analyzed by RT-qPCR
in wt and cdc48–3 cells and normalized to ACT1 transcripts.
 by guest on January 10, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2014, Vol. 42, No. 17 10979
cess. These observations indicate that interaction with tran-
scriptionally active gene loci requires an intact function of
Cdc48.
To analyze whether Cdc48 is not only recruited on ac-
tive gene loci but directly influences the transcription pro-
cess, the level of GAL10 mRNA was analyzed by reverse
transcriptase-qPCR (RT-qPCR) in wt and thermosensitive
cdc48–3 mutant cells. As shown in Figure 1D, preventing
Cdc48 function severely impairs the expression of these in-
ducible transcripts. Together these results indicate that an
intact function of the Cdc48 complex is required for an ap-
propriate transcriptional response.
Monoubiquitylated H2B levels are reduced in cdc48 mutants
Cdc48 primarily interacts with ubiquitylated proteins and
functions as a ubiquitin-selective segregase in the nuclear
chromatin environment both in yeast and higher eukary-
otic cells (22). Yeast histone H2B represents one of the most
abundant chromatin-associated targets for ubiquitylation.
Interestingly, ubiquitylated H2B (Ub-H2B) is mainly asso-
ciated with transcribed gene regions similar to the distribu-
tion of Cdc48 (Figure 1) (36). In addition, preventing H2B
ubiquitylation by deletion of Rad6, the Bre1 RING domain
or mutation of K123 prevents RNA polymerase II recruit-
ment on galactose inducible genes GAL1 and GAL10 but
not on PMA1 and results in a decreased expression of GAL
transcripts (4,37). Despite the correlation between the dis-
tribution of Ub-H2B and Cdc48 on active genes and their
effect on RNA polII recruitment, association of Cdc48 with
the PMA1 gene was not affected by the mutation of H2B
K123 (not shown). This observation indicates that ubiq-
uitylation of H2B is not sufficient to recruit Cdc48 to ac-
tive genes. To determine whether Cdc48 might influence the
amount of Ub-H2B, we analyzed H2B modification in to-
tal extracts from wt and cdc48-6 cells and compared the
H2B profile with cells deleted for the H2B ubiquitin ligase
Bre1. This approach revealed reduced levels of Ub-H2B in
both cdc48-6 and cdc48-3 cells grown at the semi-restrictive
temperature compared to wt (Figure 2A and Supplemen-
tary Figure S2). To further support these findings, copper-
inducible His-tagged ubiquitin was expressed in wt and
cdc48-6 mutant cells grown at 23◦C or the semi-permissive
temperature of 30◦C followed by purification of ubiquity-
lated proteins with nickel NTA agarose and western blot
analysis using anti-H2B antibody. This assay confirmed re-
duced levels of His6-Ub-H2B in cdc48-6 grown at 30◦C
(Figure 2B, upper panel). In contrast to ubiquitylation, the
amount of unmodified H2B was not changed under the
same conditions (Figure 2A and B middle panel).
Ubiquitylation of H2B is known to be regulated on tran-
scribed genes for an optimal transcriptional activation and
elongation (16). To analyze whether Cdc48 facilitates ubiq-
uitylation or instead protects H2B from deubiquitylation,
we performed epistasis analysis combining the cdc48-6 mu-
tant with deletions of either UBP8 or UBP10, which specif-
ically deubiquitylate Ub-H2B. As previously described, the
deletion of UBP8 strongly enhanced the amount of Ub-
H2B. However, in combination with ubp8Δ, the cdc48-6
mutation still led to a decreased detection of Ub-H2B at
30◦C. Similar results were observed for ubp10Δ although
this deletion strain showed only limited consequences on
Ub-H2B (Figure 2C). As Ubp8 and Ubp10 display par-
tially redundant activities, deletion of both DUBs resulted
in a synergistic increase in the level of Ub-H2B (Figure 2C;
(38)). Despite the major accumulation of Ub-H2B in ubp8Δ
ubp10Δ cells, disruption of functional Cdc48 was still able
to reduce the level of Ub-H2B (Figure 2C).
Together these results suggest that Cdc48 regulates the
monoubiquitylation of H2B at least on bulk histones. Al-
though an effect of Cdc48 on de-ubiquitylation cannot be
excluded, these data indicate that Cdc48 stimulates the H2B
ubiquitylation process.
Cdc48 regulates ubiquitylation of H2B on actively tran-
scribed genes
To determine whether Cdc48 modulates the occupancy of
Ub-H2B on active genes, we used a ChDIP assay to de-
tect ubiquitin-modified Flag-H2B combined with qPCR on
different active genes (15,33,39). We calculated the level of
Ub-H2B relative to the level of H2B present on each re-
gion of considered genes. In agreement with previous stud-
ies, Ub-H2B occupancy is decreased upon exchanging the
ubiquitylation site K123 against arginine (K123R) and in-
creased upon UBP8 deletion (15,33,39). As shown before,
mutation in CDC48 led to a decrease of Ub-H2B associ-
ated to five different genes both in a wt and in ubp8Δ cells
(compare cdc48-6 with wt cells, and cdc48-6 ubp8Δ with
ubp8Δ cells), whereas no significant change could be ob-
served on unmodified H2B (Figure 2D and Supplementary
Figure S3). These results indicate that Cdc48 improves the
monoubiquitylation of H2B on actively transcribed genes.
Although Ubp8, and more generally the Ubp8-containing
deubiquitylation module, is part of the histone acetyla-
tion SAGA complex, we were not able to detect differ-
ences between SAGA (ADH1, GCV2, PHO84) and TFIID-
dependent (ACT1, PMA1, PHO84) genes (40,41).
Ubx3, a cofactor of Cdc48 for H2B ubiquitylation
To further decipher how Cdc48 controls H2B ubiquityla-
tion, we analyzed the steady-state levels of Ub-H2B in mu-
tants lacking each of the seven S. cerevisiae UBX proteins.
H2B conjugated by either endogenous or copper-inducible
His-tagged ubiquitin was severely decreased in ubx3Δ cells,
whereas comparable modified H2B was observed in wt and
other mutant cells (Figure 3A). Deletion of UBX3 induced
a decrease of Ub-H2B at four different genes indicating that
Ubx3, as Cdc48, improves the monoubiquitylation of H2B
on actively transcribed genes (Figure 3B). We confirmed
that a C-terminal HA-tagged version of Ubx3 (Ubx3-HA)
specifically interacts with Cdc48 (Figure 3C; (42)). In ad-
dition, both Cdc48 and Ubx3 were found to interact with
H2B in coimmunoprecipitation assays (not shown). Finally,
in combination with ubp8Δ, UBX3 deletion led to a de-
creased accumulation of Ub-H2B at 30◦C indicating that
Ubx3, like Cdc48, is required for efficient ubiquitin conju-
gation of H2B (Figure 3D). Together these data provide evi-
dence that Ubx3 acts as a major Cdc48 cofactor to facilitate
H2B ubiquitylation.
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Figure 2. Cdc48 facilitates ubiquitylation of the histone H2B on active genes. (A) Wt, cdc48–6 or bre1Δ cells were grown at 23◦C or 30◦C. Expression levels
of H2B and Ub-H2B in whole cell lysates were analyzed by western blotting using anti H2B antibody. (B) Wt or cdc48–6 cells grown at 23◦C or 30◦C were
transformed (+) or not (–) with a plasmid encoding 6His–ubiquitin. 6His–ubiquitin conjugates were Ni-purified from cell extracts and examined by western
blotting with an anti-H2B (upper panel). Expression levels of H2B and Ub-H2B in whole cell lysates were analyzed with anti H2B blot (middle panel).
6His-ubiquitin expression and efficiency of purification was controlled using an anti-6His antibody (lower panel). Note the accumulation of high-molecular
mass ubiquitylated proteins in cdc48–6 cells at 30◦C. (C) Total extracts from indicated cells grown at 23◦C or 30◦C were analyzed by western blotting using
anti-H2B or anti-Ub-H2B antibodies. (D) Indicated cells were transformed with plasmids encoding for a Flag-tagged version of H2B (WT) or H2B-K123R
(K123R) and grown at 30◦C. Double ChIP on GCV2 and ADH1 genes was performed first with anti-Flag antibodies (right panels) and then anti-ubiquitin
antibodies. The ratio between both was then normalized to the wt strain (left panels). Histograms depict the mean and standard deviations of at least
three independent experiments. Significance of the differences observed between both strains was evaluated using Student’s t-test (*P = 0.01–0.05; **P =
0.001–0.01; ***P < 0.001).
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Figure 3. Ubx3 is a cofactor of Cdc48 for ubiquitylation of H2B. (A) Wt or ubxΔ cells grown at 30◦C were transformed (+) or not (–) with a plasmid
encoding 6His–ubiquitin. Expression levels of H2B and Ub-H2B in whole cell lysates were analyzed with anti H2B blot. (B) Ubiquitylation of H2B an
actively transcribed genes was analyzed by ChIP using anti-UbH2B and anti H2B antibodies in wt and ubx3Δ cells. The Ub-H2B/H2B ratio in wt and
mutant cells was normalized to the wt cells. Histograms depict the mean and standard deviations of at least three independent experiments. Significance
of the differences observed between both strains was evaluated using Student’s t-test (*P = 0.01–0.05; **P = 0.001–0.01; ***P < 0.001). (C) Lysates from
wt cells expressing Ubx3-HA or Rad6-HA as a control were immunoprecipitated using anti-HA, anti-Cdc48 or mock antibodies and analyzed by western
blotting with the indicated antibodies. (D) Total extracts from indicated cells were analyzed by western blotting using anti-H2B or anti-Ub-H2B antibodies.
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The Cdc48/Ubx3 complex controls the recruitment of Lge1,
a cofactor of the Bre1 ligase, on active genes
As previously mentioned, ubiquitylation of yeast H2B is
achieved by Rad6 as an E2, Bre1 as the E3 ubiquitin ligase
and its Lge1 cofactor (8–12). To understand how Cdc48 and
Ubx3 facilitate ubiquitylation of H2B, we first performed
genetic analyses and found that combining LGE1 deletion
with the cdc48-6 mutation or ubx3 deletion led to synthetic
sickness of double mutant cells (Figure 4A) thus indicating
a clear genetic interaction between LGE1 and both CDC48
and UBX3. In agreement with this result, the cotranscrip-
tional recruitment of Lge1-HA on transcribing genes was
severely reduced in cdc48-6 compared to wt cells without
significant effects on CTD association with indicated genes
(Figure 4B). Importantly, genomic C-terminal HA-tagging
of Lge1, as well as Rad6 and Bre1, did not affect their
enzymatic activity (Supplementary Figure S4A). The low-
ered cotranscriptional recruitment of Lge1 was correlated
with decrease of Lge1-HA expression level in cdc48-6 cells
at 30◦C, whereas cdc48-6 did not specifically affect tagged
Rad6-HA and Bre1-HA protein level (Figure 4C). To fur-
ther determine whether the Cdc48-regulated recruitment of
Lge1 to active genes was only due to this expression regu-
lation and/or to a direct effect, we analyzed the expression
of Lge1-HA and Bre1-HA upon UBX3 deletion. As shown
in Figure 4D, expression of Bre1 and Lge1 were compara-
ble in wt and mutant strain. ChIP analysis revealed that co-
transcriptional recruitment of Lge1-HA was impaired upon
UBX3 deletion whereas recruitment of Bre1-HA was unaf-
fected (Figure 4E and not shown).
Coimmunoprecipitation experiments between Ubx3 and
Lge1 (Figure 4F) further confirm that Cdc48 cooperates
with its cofactor Ubx3 in cotranscriptional recruitment of
the H2B ubiquitylation machinery to active genes by inter-
action between Ubx3 and Lge1.
p97 controls H2B ubiquitylation in human cells
The identification of Cdc48 as a regulator of H2B ubiqui-
tylation in yeast prompted us to analyze whether this func-
tion is conserved across evolution. To determine whether
p97 might influence ubiquitylation of H2B, C2C12 my-
oblast cells were treated with increasing doses of N2,N4-
dibenzylquinazoline-2,4-diamine (DBeQ), a selective and
reversible ATP-competitive p97 inhibitor (43). The ubiqui-
tylation status of H2B was analyzed by western blotting us-
ing specific antibodies (Figure 5A). Densitometric analysis
revealed that the Ub-H2B/H2B ratio increased by a factor
of 2.4 and 2.5 upon treatment with 5 and 10 M DBeQ,
respectively. To confirm that inhibiting the ATPase activ-
ity of p97 led to an increased Ub-H2B/H2B ratio, H2B
ubiquitylation was analyzed using U2OS cells stably ex-
pressing tetracycline-inducible and myc-tagged WT or AT-
Pase inactive E578Q mutant p97 (35). While expression of
tetracycline-induced wt p97 did not change expression of
Ub-H2B, induction of p97 E578Q mutant led to a 4-fold
increase of the Ub-H2B/H2B ratio (Figure 5B). These ex-
periments show that inhibiting the ATPase activity of p97
promotes an increase in monoubiquitylated H2B.
Given that H2B ubiquitylation is down-regulated upon
differentiation of human myoblasts into myotubes, it is in-
triguing to note that missense mutations of p97 are linked
to a dominantly inherited myopathy (IBMPFD) (19). We
therefore analyzed ubiquitylation of H2B along differen-
tiation of primary myoblasts of IBMPFD myopathy pa-
tients compared to myocytes from unaffected age- and sex-
matched individuals. The myopathy patient cells carry a
point mutation on a highly conserved residue R155H that
does not affect the ATPase activity (44–46). As shown in
Figure 5C, the p97R155H mutation did not significantly alter
the in vitro differentiation into myotubes as indicated by the
expression of MyoD. As previously described, H2B ubiqui-
tylation was severely decreased early in differentiation (48
h after induction of differentiation), whereas this reduction
was significantly delayed in IBMPFD patient cells. Together
these data show that p97 (functional ATPase activity and in-
tact N-terminal domain) is required for controlling the ap-
propriate Ub-H2B/H2B ratio in human muscle cells.
DISCUSSION
Our results indicate a multifaceted role for Cdc48/p97 in
controlling transcriptional processes. In yeast, we demon-
strate that Cdc48 together with its core cofactor Npl4, is re-
cruited to active chromatin in a transcription-coupled man-
ner, associates with the transcribed portion of the genes
and is required for the proper expression of inducible genes.
Moreover, Cdc48 complexes are critical for maintaining
correct levels of ubiquitylated H2B. By combining Cdc48
mutations with deletion of H2B-specific deubiquitylating
enzymes, Ubp8 and Ubp10, we found that Cdc48 acts pri-
marily on the ubiquitylation process, suggesting that it stim-
ulates the recruitment or activity of the ubiquitylation ma-
chinery. Indeed, Cdc48 is required for the cotranscriptional
recruitment of the Lge1 cofactor to chromatin. This newly
described function of Cdc48 is mediated by a specific co-
factor from the UBX family, Ubx3. Our results favor the
model that Cdc48/Ubx3 facilitate or stabilize the binding
of the H2B ubiquitylation machinery to active genes via in-
teraction between Ubx3 and Lge1. These results are con-
sistent with a role of Cdc48 as a platform coordinating the
recruitment of processing factors (26), here Lge1, with spe-
cific targets on chromatin and suggest a possible function
for this chaperone in chromatin remodeling. Beyond Lge1,
the association of Cdc48 with transcribing genes raises the
intriguing possibility that Cdc48 is a common integrator
that controls multiple facets of the transcriptional process.
In human cells, different approaches affecting the cat-
alytic activity of p97 or its cofactor-binding N-terminal do-
main led to a significant increase of Ub-H2B level. In par-
ticular, we observed that loss of H2B ubiquitylation dur-
ing myogenic differentiation was significantly reduced in
IBMPFD patient cells. Pathogenic mutations in p97 are
primarily in the N-terminal domain implicated in ubiqui-
tin binding and protein–protein interactions (45,47). The
R155H mutation affects a highly conserved residue and is
by far the most common, accounting for ∼50% of all af-
fected individuals (44,47,48). The p97R155H mutation is nei-
ther associated with altered binding of known cofactors nor
with decrease in ATPase activity (44,45). Since this muta-
tion did not significantly influence the myoblast differenti-
ation, changes in Ub-H2B level were likely not caused by
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Figure 4. Cdc48 controls the expression and cotranscriptional recruitment of Lge1. (A) Note that 5-fold serial dilutions of wt and indicated mutant cells
were cultured in rich medium at 30◦C. (B) ChIP experiments were performed on extracts prepared from WT or cdc48–6 cells grown overnight at 30◦C
using anti RNA polymerase II (CTD) or anti-HA (Lge1-HA) antibodies. Histograms depict the mean and standard deviations of at least three independent
experiments. Significance of the differences observed between both strains was evaluated using Student’s t-test (*P = 0.01–0.05; **P = 0.001–0.01; ***P <
0.001). (C) Expression of HA-tagged versions of Rad6, Bre1 and Lge1 were analyzed in total extracts from WT or cdc48–6 cells by western blotting using
anti-HA antibodies or anti-Mex67 antibodies as loading control. (D) Expression of Lge1-HA and Bre1-HA were analyzed in total extracts from WT or
ubx3Δcells by western blotting using anti-HA antibodies or a non-specific protein as loading control. (E) ChIP experiments were performed on extracts
prepared from WT or ubx3Δ cells grown overnight at 30◦C using anti RNA polymerase II (CTD) or anti-HA (Lge1-HA) antibodies and analyzed as in
B. (F) Lysates from wt cells expressing Ubx3-HA and Lge1-Myc or Ubp8-Myc as a control were immunoprecipitated using anti-HA or mock antibodies.
and analyzed by western blotting with the anti-HA and anti-Myc antibodies.
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Figure 5. Human p97 is required for a proper level of H2B ubiquityla-
tion in human muscle cells. (A) Inhibition of the p97 function by DBeQ
treatment affects in turn histone H2B ubiquitylation. C2C12 myoblasts
were treated with indicated concentration of DBeQ (5 and 10 M) for 2
h. Next, total cell lysates were separated by SDS-PAGE and subjected to
western blot analysis with anti-p97, anti-H2B and anti-H2B-Ub antibod-
ies. -tubulin was used as a loading control. Densitometric analysis done
by Image J software, results were normalized to the control condition and
expressed as the Ub-H2B/H2B ratio. (B) Overexpression of the ATPase
inactive p97 form increases the ubiquitylation level of histone H2B. Over-
expression of Myc-tagged p97 or ATPase inactive p97-E578Q mutant in
U2OS cells was induced by incubation with tetracycline (1 g/ml) for 16
h. Next, total lysates from non-induced (–) and tetracycline-induced (+)
cells were separated by SDS-PAGE and subjected to western blot analy-
sis with anti-Myc, anti-H2B-Ub and anti-H2B antibodies. -tubulin was
used as a loading control. Densitometric analysis done by Image J soft-
ware, results were normalized to the control condition and expressed as
the Ub-H2B/H2B ratio. (C) Delayed depletion of H2Bub during myogenic
differentiation of IBMPFD primary human myoblasts. Lysates of control
and IBMPFD primary human myoblasts (MB) and those corresponding
to the indicated number of hours after induction of their differentiation
(48 and 72 h) were analyzed by western blot using antibodies that recog-
nize the indicated proteins. -Tubulin was used as a loading control. MT,
differentiated myotubes.
reduced cell proliferation. The most likely hypothesis is that
the R155 residue affects binding of p97 with specific cofac-
tor(s) and thus reduces Ub-H2B levels. It is worth noting
that the yeast Ubx3 has no known human ortholog. In ad-
dition, by introducing the R165H (equivalent of R155) mu-
tation in the yeast Cdc48, we could not detect any effect
on Ub-H2B (not shown). Similarly, expression of human
wt or p97R155H mutant in cdc48–6 cells did not induce any
changes in Ub-H2B levels (not shown). These data suggest
that the human cofactor mediating the role of p97 in con-
trolling Ub-H2B in muscle cells is not conserved in yeast.
Although there is no ortholog of Lge1 in human cells, there
may be additional cofactors that are recruited to chromatin
in a p97-dependent manner. For example, the WAC cofac-
tor mediates the cotranscriptional recruitment of the H2B
ubiquitin ligase RNF20/40 (13). Further studies will be nec-
essary to analyze whether WAC could be an indirect target
of p97 and better understand the regulatory role of p97 that
underlies transcriptional elongation and epigenetic changes
during myogenic differentiation.
Together, our results suggest that both in yeast and mam-
mals, Cdc48/p97 serves as an integrating platform for mod-
ulation of histone ubiquitylation. Interestingly, however,
the molecular mechanisms diverge to include different co-
factors and different functionalities. Given the fact that
Cdc48/p97 is located throughout the cell and exerts regu-
lation of many cellular functions, it might contribute to the
integration of cellular processes, adjusting inducible signal-
ing pathways with the regulation of chromatin-associated
ubiquitin-based modifications.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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